AIHC Capital Management Ltd
In its 13F for Q4 2025 (holdings as of December 31, 2025, filed February 5, 2026), AIHC Capital Management Ltd reported 6 stock positions worth $106.7 million. Its top holding was Revolution Medicines (RVMD) at 67.2% of the portfolio, followed by Protagonist Therapeutics (PTGX, 15.5%) and Arrivent Biopharma (AVBP, 12.2%).
- Most Recent 13F
- Q2 2026
- Location
- CENTRAL, K3
- CIK
- 0002103725
- Portfolio Value
- $106.7M (Q4 2025)
- SEC Filing
- 0001172661-26-000478 ↗ filed Feb 5, 2026
Holdings Value
Holdings 6 stocks · $106.7M
| RVMD Revolution Medicines Inc. | 67.21% | 900,392 | $71.7M | — |
| PTGX Protagonist Therapeutics Inc. | 15.54% | 189,823 | $16.6M | — |
| AVBP Arrivent Biopharma Inc. | 12.16% | 644,788 | $13.0M | — |
| COGT Cogent Biosciences Inc. | 3.33% | 100,000 | $3.6M | — |
| NBP Novabridge Biosciences | 1.54% | 413,979 | $1.6M | — |
| KRRO Korro Bio Inc. | 0.23% | 30,265 | $242K | — |
Portfolio Sells Q4 2025
No earlier filing to compare with.
Portfolio Buys Q4 2025
No earlier filing to compare with.